| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |